Search Results

1 - 10 of 17 items :

  • Pharmacy, other x
Clear All
A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2

-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute, Clin. Orthop. Relat. Res. 471 (2013) 2540-2547; DOI: 10.1007/s11999-012-2644-5. 28. E. R. Balmayor, G. A. Feichtinger, H. S. Azevedo, M. van Griensven and R. L. Reis, Starch-poly-ecaprolactone microparticles reduce the needed amount of BMP-2, Clin. Orthop. Relat. Res. 467 (2009) 3138-3148; DOI: 10.1089/ten.2006.0194. 29. E. Zerath, X. Holy, B. Noël, A. Malouvier, M. Hott and P. J. Marie, Effects of BMP-2 on osteoblastic cells and on skeletal

Open access
The therapeutic agents that target ATP-sensitive potassium channels

.1038/311271a0. 11. A. E. Spruce, N. B. Standen and P. R. Stanfield, Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane, Nature 316 (1985) 736–738; DOI: 10.1038/316736a0. 12. S. J. Ashcroft and F. M. Ashcroft, Properties and functions of ATP-sensitive K-channels, Cell. Signal . 2 (1990) 197–214; DOI 10.1016/0898-6568(90)90048-F. 13. N. B. Standen, J. M. Quayle, N. W. Davies, J. E. Brayden, Y. Huang and M. T. Nelson, Hyperpolarizing vasodilators activate ATP-sensitive K + channels in arterial smooth muscle, Science 245

Open access
Pitavastatin-attenuated cardiac dysfunction in mice with dilated cardiomyopathy via regulation of myocardial calcium handling proteins

-121; DOI: 10.1016/j.rvsc.2012.07.027. 19. K. Suzuki, B. Murtuza, N. Suzuki, R. T. Smolenski andM. H. Yacoub, Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure, Circulation 104 (2001) 1213-1217; DOI: 10.1161/hc37t1.094929. 20. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J. D. Molkentin, Y. Zou and I. Komuro, p53-induced inhibition of Hif-1 causes cardiac dysfunction during

Open access
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe

, Todorovic SM. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. Psychopharmacology (Berl). 2014; 231:3503-15. [4] Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, Chemin J. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci. 2009; 29:13106-14. [5] Berthier C, Monteil A, Lory P, Strube C. Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient

Open access
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease

. Santos, H. Quesada, M. Naceur Slimane, W. Wahli. J. Julve, M. Vazquez-Carrera, M. Jauhiainen, F. Blanco-Vaca and J. C. Escola-Gil, PPAR-beta/delta activation promotes phospholipid transfer protein expression, Biochem. Pharmacol. 94 (2015) 101-108; DOI: 10.1016/j.bcp.2015.01.016. 47. L. Salvado, E. Barroso, A. M. Gomez-Foix, X. Palomer, L. Michalik, W. Wahli and M. Vazquez- Carrera, PPARbeta/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism

Open access
Biochemical aspects of KB-28 compound on physically loaded study subjects

Open. 2015;1(9):1-4. http://doi.org/10.1186/s40798-015-0012-1 18. Kits Van Heijningen AJ, Kemp A. Free and fixed glycogen in rat muscle. Biochem J. 1955;59:487-91 19. Selye H. 1974. Stress without Distress. Philadelphia: Lippincott. 20. Baker JS, McCormick MC, Robergs RA. Interaction among skeletal muscle metabolic energy systems during intense exercise. J Nutr Metab . 2010;Article ID 905612:2-13. http://dx.doi.org/10.1155/2010/905612 21. Eizadi M, Nazem F, Zarifyan A, Eghdami A, Khorshidi D. The Effect of Chronic Intake of L

Open access
Chromone-3-aldehyde derivatives – sirtuin 2 inhibitors for correction of muscular dysfunction

REFERENCES 1. Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis . 2015;7(10):E418-E438. 2. Gea J, Barreiro E, Orozco-Levi M. Skeletal muscle adaptation to disease states. In: Bottinelli R, Reggiani C, editors. Skeletal Muscle Plasticity in Health and Disease: From genes to whole muscle. Dordrecht: Springer, 2006: 315-60. 3. Staud R. Peripheral and Central Mechanisms of Fatigue in Inflammatory and Non

Open access
BMI in patients with obstructive sleep apnea

., 509, 3, 1990. 4. Kuźmińska M., Marcinkowska-Suchowierska E.: Otyłość a obturacyjny bezdech senny. Post. Nauk Med., 9, 26, 2013. 5. Mayer P., Pepin G., Bettega D., et al.: Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients. Eur. Respire J., 1801, 9, 1996. 6. Ono T., Lowe A.A., Ferguson K.A., et al.: Associations between upper airway structure, body position and obesity in skeletal Class I male patients with obstructive sleep apnea. Am. J. Orthod. Dentofac. Orthop

Open access
Assessment of MT-279 compound effect on physical endurance of rats under conditions of chronic hypokinesia

Parkinson's disease. Clin. Neurol. Neurosurg., 587-590, 5, 2013. DOI: 10.1016/j. clineuro.2012.07.014. 6. Margolis L. M., Rivas D. A. Implications of Exercise Training and Distribution of Protein Intake on Molecular Processes Regulating Skeletal Muscle Plasticity. Calcif. Tissue Int., 211-221, 3, 2015. 7. Oliynyk S., Oh S. The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance. Biomol. Ther., 446-56, 20(5), 2012. DOI: 10.4062/ biomolther.2012.20.5.444 8. Pierre N. et al

Open access
In vitro study: binding of 99mTc-DPD to synthetic amyloid fibrils

amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart, 78, 1, 1997. 7. Falk R.: Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am. J. Cardiol., 54, 8, 1984. 8. Falk R. et al.: Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am. J. Cardiol., 51, 5, 1983. 9. Fogelman I. et al.: A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. J. Nucl. Med., 22, 10, 1981

Open access